Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

RGMb Activators

RGMb activators, also known as Repulsive Guidance Molecule b activators, belong to a specialized chemical class designed to modulate the activity of a protein called RGMb. RGMb, short for Repulsive Guidance Molecule b, is a glycosylphosphatidylinositol (GPI)-anchored membrane protein that plays crucial roles in various cellular processes. RGMb activators are chemical compounds or molecules that have been developed to interact with RGMb, either by binding to it directly or by affecting its downstream signaling pathways. These activators can influence the biological functions associated with RGMb, making them valuable tools for understanding its physiological roles.

RGMb activators typically exhibit a high degree of specificity for their target protein, ensuring minimal off-target effects. They are designed to modulate RGMb's activity in a controlled manner, thereby offering researchers the ability to manipulate cellular responses associated with RGMb. These chemical compounds may act as agonists, promoting the activation of RGMb, or antagonists, inhibiting its activity, depending on their specific mechanisms of action. By using RGMb activators, scientists can gain insights into the intricate molecular mechanisms in which RGMb participates, shedding light on its involvement in processes such as axon guidance during development, iron metabolism regulation, and potentially other physiological functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LDN-214117

1627503-67-6sc-507451
5 mg
$165.00
(0)

LDN-214117 is another small molecule inhibitor of BMP type I receptors, and its use can indirectly activate RGMb by inhibiting BMP receptor signaling.

K02288

1431985-92-0sc-488981
5 mg
$330.00
(0)

K02288 is a small molecule inhibitor of BMP type I receptors, potentially indirectly activating RGMb by inhibiting BMP receptor activity.

GSK J1

1373422-53-7sc-391113
sc-391113A
10 mg
50 mg
$193.00
$813.00
(0)

GSK-126 is an inhibitor of the histone methyltransferase EZH2. It may indirectly activating RGMb expression and signaling by altering chromatin modifications.